Overview of the current status of genetically modified plants in Europe as compared to the USA
Overview of the current status of genetically modified plants in Europe as compared to the USA
复制标题
DOI：
10.1078/0176-1617-01031
复制
发表时间：
2003-07-01
影响因子：
4.3
通讯作者：
Brandt, P
中科院分区：
文献类型：
--
作者：
Brandt, P
转基因作物已经在欧盟成员国的1726个试验性释放和美国的7815个试验性释放中进行了测试。2001年全球转基因作物商业化种植面积有望达到5000万公顷，而欧盟的转基因作物商业化产量仅为几千公顷，仅占世界总产量的0.03%左右。在美国、加拿大和其他国家已经被允许种植和投放市场的50多种转基因作物与欧盟成员国允许相同用途的5种转基因作物之间存在着巨大的差距，这些作物仍在等待列入《农业植物物种共同目录》。“绿色基因技术”在欧盟的进一步发展将是一个公众接受和行政立法的问题。
Genetically modified crops have been tested in 1,726 experimental releases in the EU member states and in 7,815 experimental releases in the USA. The global commercial cultivation area of genetically modified crops is likely to reach 50 million hectares in 2001, however, the commercial production of genetically modified crops in the EU amounts to only a few thousand hectares and accounts for only some 0.03% of the world production. A significant gap exists between the more than fifty genetically modified crop species already permitted to be cultivated and to be placed on the market in the USA, Canada and other countries and the five genetically modified crop species permitted for the same use in the EU member states, which are still pending inclusion in the Common Catalogue of agricultural plant species. The further development of the ''green gene technology'' in the EU will be a matter of public acceptance and administrative legislation.